On this day, all the operating rooms at Mayo Clinic were very busy.
Doctors across the United States were excited. Seeing is believing. It seemed that these magical "laparoscopy" machines could completely replace human hands to perform delicate surgeries.
The key is also the quick recovery time of minimally invasive surgery.
In foreign hospitals, the bed turnover rate is very fast. After an operation, Chinese patients tend to stay in the hospital for a week or two, while in Europe and the United States, patients can be discharged in two or three days.
This will bring about a series of problems such as postoperative recovery and infection.
Now minimally invasive surgery has solved this problem. For example, after gallbladder surgery, the patient can be discharged from the hospital on the third day after the operation. There will be no infection and the patient does not need to stay in bed. How simple is that?
So all these more than a thousand top doctors are thinking: I also want to learn minimally invasive surgery.
Chen Xia’s goal was achieved.
Now such high popularity and high traffic can be monetized and converted into high profits.
Otherwise, why would he build a factory and buy a chip production line? Was it out of love? Out of responsibility? Because he wanted to dedicate his life to medicine?
Bullshit, for the sake of money, he is now penniless.
On the evening after the teaching surgery, Chen Xia was surrounded by the directors of many American hospitals and managers of major pharmaceutical companies.
Childe Steve, Vice Chairman of the Mayo Clinic, and Chen Xia were also old friends. He got straight to the point and said:
"Chen, we'll talk about organ transplant drugs and technology later. But we at Mayo Clinic need to import the first batch of the many types of laparoscopic machines you invented. The larger the quantity, the better."
Jamie, the director of Cliff Clinic, was anxious:
"No, no, Chen. We at Cliff are very interested in your laparoscopic technology and are very willing to buy it. Don't worry, you can name any price, and we will not bargain."
Chen Xia was about to speak when he was interrupted by Marcia, the vice president of Pfizer Pharmaceuticals.
"Chen, I want to remind you that this is a medical device. Without the FDA's approval, it cannot be used directly in clinical practice, nor can it be sold directly to hospitals. Otherwise, it will be illegal.
So you need allies like us to help you with the relevant legal procedures and filings. Of course, you also understand our requirements: we want to have exclusive agency rights in the North American market."
Look, the capitalists are really powerful. They pointed out the problem right away.
Before Chen Xia could speak, Blair, the president of Stryker, started shouting:
"Chen, our cooperation on antibiotics is very pleasant, isn't it? I think you should consider the WHO's advice and not put all your eggs in one basket. You can't always work with Pfizer. The patent royalties they pay are too low.
If you work with us at Stryker, we can build a joint venture and we can be their sole agent. No matter how much Pfizer offers, we can definitely give them at least 3 percentage points lower than theirs. How about that?
Marcia got angry when she heard this. "Mr. Blair, you are slandering our close relationship and trying to sow discord between us in front of everyone in the hall. Don't you feel ashamed?"
Blair, on the other hand, straightened his collar smugly. "Don't think I don't know that Pumpkin Vine collects less royalties from you guys for the drug patents they're collaborating on. Aren't you just undermining your own allies?"
The scene suddenly became noisy.
Chen Shuqin and Chen Xia looked at each other and burst out laughing.
As long as they take over the American market, it means opening the door to the world's medical equipment market. The more they hype it up and the more intense the competition, the more successful the "laparoscopic project" will be.
Chen Xia knocked on the table and said with a smile:
"Ladies and gentlemen, business negotiations cannot be easily concluded. We must negotiate. We can give the sales rights for both North and South America to one company. Of course, the highest bidder will win.
Maybe you should go back now and prepare to draft some cooperation plans, such as how much price you are willing to pay for the goods, and how much effort you are willing to put in promoting the laparoscope?
And don't worry, hospital chairmen and deans. Ms. Marcia is right. We can't sell the machine directly to you because we need an agency to help us with FDA approval. But I can guarantee that we will give preferential treatment to the North American market."
When the representatives from several pharmaceutical companies heard this, they all understood what was going on and rushed home to make plans.
As long as the price is not too outrageous, Chen Xia will probably still choose Pfizer, after all he owns a 15% stake.
But if the price-profit difference is too great, he doesn't mind supporting another pharmaceutical company, for fear that one company will feed too many.
Chen Xia had no choice but to choose a product agent, the reason being the same as the drug patent.
For example, with the FDA in the United States, if you don't have certain connections, it will be extremely difficult to apply on your own. It may take you three to five years, and then you will be asked to provide additional information, or they will constantly question you until you lose your patience.
After entering the 1990s, the invention of drugs and medical devices will enter the fast lane
Chen Xia must hurry up. If the laparoscopic machine alone is delayed for several years, all of Pumpkin Vine's subsequent plans will be disrupted.
For example, Chen Xia has already asked people to start researching hearing aid projects, various artificial joints in orthopedics, interventional stent topics, and recently, color ultrasound machines, gamma knives, fully automatic five-category blood routine analyzers, biochemical analyzers and other electronic products.
Although Chen Xia has prototypes of these in the space hospital, it still requires a lot of funds and scientific research to completely imitate them.
This requires money.
The problem is that Chen Xia has no money now.
Therefore, he also hopes that the laparoscopic machine project can complete market application and promotion as soon as possible so that he can get the agency fee to ease his financial pressure.
He really couldn't bear to spend that gold.
To Chen Xia's surprise, the American doctors were so enthusiastic that they felt one day's teaching surgery was far from enough and insisted on adding a few more.
And you can't just hang out at the Mayo Clinic, you have to go to your own hospital too. The United States is so big, not all doctors have time to come here.
As a result, the teaching surgery that was originally planned for one day was stretched to half a month. The "surgical expert team" composed of doctors from China and Hong Kong taught from the east coast to the west coast, and from the south to the north.
What happened next?
Well-informed doctors from Europe and America also rushed to the United States to watch the laparoscopic surgery process on site.
Pfizer Pharmaceuticals finally won the exclusive agency rights in North America, and Chen Xia still had to give in. After all, the two parties had cooperated very happily before, and the conditions offered this time were also quite good.
Therefore, all expenses of this "China-Hong Kong Doctor's Trip to China" were reimbursed by Pfizer, which saved Chen Xia a lot of money.
Continue read on readnovelmtl.com